First Manhattan’s Oyster Point Pharma OYST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-260,553
Closed -$3.03M – 1718
2022
Q1
$3.03M Sell
260,553
-327,282
-56% -$3.9M 0.01% 310
2021
Q4
$10.7M Buy
587,835
+143,346
+32% +$1.82M 0.04% 164
2021
Q3
$5.27M Buy
444,489
+73,200
+20% +$1.07M 0.02% 216
2021
Q2
$6.38M Hold
371,289
– – 0.02% 202
2021
Q1
$6.79M Buy
371,289
+191,765
+107% +$4.02M 0.03% 196
2020
Q4
$3.38M Buy
179,524
+69,800
+64% +$1.51M 0.02% 259
2020
Q3
$2.32M Buy
109,724
+11,547
+12% +$270K 0.01% 281
2020
Q2
$2.84M Buy
98,177
+3,414
+4% +$103K 0.02% 271
2020
Q1
$3.32M Buy
+94,763
New +$3.07M 0.02% 247

Other funds holding OYST

First Manhattan's OYST Position: Q2 2022 in Review

First Manhattan sold out of Oyster Point Pharma (OYST) in Q2 2022, closing a stake of 260,553 shares — an estimated $3.03M sold.

First Manhattan first reported a position in OYST in Q1 2020 and held it in 9 quarters. The position peaked at $10.7M in Q4 2021. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

  • First Manhattan reported no remaining Oyster Point Pharma position as of Q2 2022 after selling out during the quarter.
  • First Manhattan sold 260,553 Oyster Point Pharma shares in Q2 2022, an estimated $3.03M.
  • First Manhattan first reported a position in Oyster Point Pharma in Q1 2020 and held it in 9 quarters.
  • First Manhattan's Oyster Point Pharma position peaked at $10.7M in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Oyster Point Pharma as of Q2 2022.

Based on First Manhattan's 13F filing for Q2 2022, filed 15 Aug 2022.